Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tele-dermatology of Skin Cancer: a Randomized Trial Comparing Remote Assessment With Conventional Visits in a Cohort of Local Health Authority Employees in the Province of Bergamo (the Shoot the Mole Study)

NCT02902822 is registered in ClinicalTrials.gov with Centro Studi Gised as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02902822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tele-dermatology of Skin Cancer: a Randomized Trial Comparing Remote Assessment With Conventional Visits in a Cohort of Local Health Authority Employees in the Province of Bergamo (the Shoot the Mole Study)
Lead sponsor
Centro Studi Gised
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2016
Completion date
May 31, 2019
Enrollment
461 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis, basal cell carcinoma, erysipelas, herpes zoster, impetigo, melanoma, molluscum contagiosum, squamous cell carcinoma, tinea, warts